News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beijing Double-Crane Pharmaceutical Co., Ltd. Buys Enshi Pharma for $13.7 Million


1/3/2011 9:37:04 AM

ChinaBio Today -- Beijing Double-Crane Pharmaceutical will acquire Shenyang Enshi Pharmaceutical from Enshi Internation for 90 million RMB ($13.7 million). Enshi Pharma produced just 2.4 million RMB of revenue during the first four months of 2010, creating a loss of 3 million RMB. Double-Crane said the acquisition would boost production capacity of its cephalosporin antibiotics. More details....

Read at ChinaBio Today
Read at News Release

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES